Trial Profile
Clinical evaluation of valaciclovir hydrochloride: 256U87 in patients with chickenpox - open uncontrolled study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Aug 2023
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary)
- Indications Chickenpox
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 18 Nov 2005 New trial record.